Dr Leanne Teoh is a pharmacist and dentist, lecturer of dental therapeutics and an early career postdoctoral researcher at the Melbourne Dental School. Her research focus is on various aspects of medicine use in dentistry and dental prescribing practices. She co-authored the Therapeutic Guidelines Oral and Dental Version 2, is on the editorial board for the journal BMC Oral Health, and is part of the Australian Dental Association Therapeutics Committee. She is a lecturer and coordinator for the dental therapeutics program for the Doctor of Dental Surgery and Bachelor of Oral Hygiene courses at the University of Melbourne.
As an invited speaker, Leanne has presented both locally and internationally in various forums, including the Therapeutic Goods Administration, FDI World Dental Federation and International Association for Dental Research.
Leanne has received several awards and scholarships, including the Rowden White Scholarship, International College of Dentists Community Oral Health Award for 2018, and the Ernest Joske Award in 2020 at Melbourne Dental School for research impact and publications. She is a founding member of the Global Antimicrobial Resistance Dental Network for the FDI World Dental Federation.
While managing dental pain is an integral part of clinical practice, the use of opioids in Australian dentistry has increased in recent years. This talk will focus on opioids in dentistry, including their current recommendations, limitations and adverse effects. Dr Teoh will also present on how dental prescribing practices can have wider implications in the opioid crisis, and discuss the usefulness of real time prescription monitoring programs.
Miss the live conference? You can now watch the conference on demand from the comfort of your own home.